MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) announced new preclinical pharmacology data showing that its cannabinoid analog Mira-55 displays a distinct mechanism ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE